Insomnia
Pipeline by Development Stage
On Market (1)
Approved therapies currently available
Competitive Landscape
45 companies ranked by most advanced pipeline stage
+15 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 11,484 patients across 50 trials
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
Insomnia Prevalence and Treatment Impact on Systemic Hypertension
An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia
Suvorexant and Sleep/Delirium in ICU Patients
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
Suvorexant and Trauma Related Insomnia
A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
Zolpidem Postmarketing Study in Adolescent Patients With Insomnia
Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography
Safety of Ramelteon in Elderly Subjects
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Alternative Dosing Regimens in the Pharmacotherapy of Insomnia
A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
Ramelteon for Insomnia Comorbid With Asthma
Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)
Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)
VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)
Efficacy of Ramelteon in Subjects With Chronic Insomnia
Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia
Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia
Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children
the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations
A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment
Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject
Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.